Hepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survival

Abstract

Over the last 10 years, the patient survival had a significant increase which was mainly a result of the optimal therapeutic selections according to disease stages in this center. However, the proportion of patients diagnosed at early stages of HCC remained low and did not increase, a result calling for implementing surveillance system for at risk patients.